Search

  • Sort by

  • Category

  • Post Type

  • Reset

Fighting fake drugs

December 1, 2007
Posted in

Judicial interpretations concerning the manufacture and selling of fake drugs were published by the State Food and Drug Administration (SFDA) on Wednesday to solicit public opinion. The interpretations jointly drafted by the Supreme People's Court and Supreme People's Procuratorate are meant to curb the rampant making and selling of fake medicines, which have posed a serious threat to the lives…

Read More

Watchdog issues alert over four Chinese medicines

November 30, 2007
Posted in

LONDON (Reuters) – People should stop taking four traditional Chinese medicines on sale in Britain that contain an acid linked to cancer and kidney failure, the drug safety watchdog said on Thursday. The Medicines and Healthcare products Regulatory Agency (MHRA) said patients who have taken the medicine should see their doctor immediately. Officials seized 6,500 packets of the product in…

Read More

Regulating the online drug marts

November 29, 2007
Posted in
Read More

Medicines recalled as counterfeits still a threat

November 29, 2007
Posted in

Anti-impotence drugs, skin-lightening products, steroids, antidepressants and weight-loss drugs were among the products seized by officers of the Irish Medicines Board (IMB) last year. In total, the IMB seized 96,487 tablets, 41,361 capsules, 52,873 liquids and 5,652 creams. It had 797 enforcement cases during the year — a big jump on the 430 orders in 2005. It received 1,900 reports…

Read More

They’re Not Going to Take It

November 28, 2007
Posted in ,

Recognizing the growing threat of the availability of counterfeit drugs worldwide, the Medicines and Healthcare Regulatory Products Agency (MHRA) – Britain's version of the FDA – last week published its first Anti-Counterfeiting Strategy. The strategy sets out the MHRA's approach to combating this threat for the next three years, including the launch of a new 24-hour hotline for reporting suspected counterfeit medicines and devices.

Read More

Dangerous counterfeit drugs

November 27, 2007
Posted in

Legislation is pending that will open United States borders to imported prescription drugs. If it passes, America could be flooded with dangerous copycat and counterfeit drugs from China and other countries with poor records on consumer safety. If we can't ensure safe children's toys from abroad, how can we ensure safe prescription drugs? Proponents promise that imported drugs will bring…

Read More

Shi YQ, Yao J, Liu F, Hu CQ, Yuan J, Zhang QM, Jin SH. Establishment of an HPLC identification system for detection of counterfeit steroidal drugs. J Pharm Biomed Anal. 2008;46(4):663-9.

November 27, 2007
Posted in ,

A set of simple HPLC methods employing UV detection were developed for detection of counterfeit drugs by the qualitative and quantitative analysis of nine steroidal drugs, ethinylestradiol, diethylstilbestrol, norethisterone, norgestrel, methyltestosterone, medroxyprogesterone acetate, progesterone, testosterone propionate and nilestriol. The methods were based on studies of the relationships between the retention factors (k) of the nine compounds and the percentages of…

Read More

MHRA launches new action plan to combat UK counterfeit hub

November 26, 2007
Posted in

The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle the recent surge in drug fakes head on. While drug counterfeiters tend to manufacture their illegitimate wares in locations such as China or India, the UK has become a key…

Read More

SAFEDRUG.pdf

November 26, 2007

SAFEDRUG.pdf

Read More

Bryan A. Liang, MD, PhD, JD

November 26, 2007
Posted in

Vice President Bryan A. Liang, Ph.D, M.D., J.D. Professor of Anesthesiology Director, San Diego Center for Patient Safety, University of California San Diego School of Medicine Professor Bryan A. Liang is Professor of Anesthesiology and Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine as well as Vice President, Partnership for Safe Medicines. Professor Liang’s research, policy, and advocacy…

Read More